1. Disrupting Mycobacterium smegmatis biofilm using enzyme-immobilized rifampicin loaded silk fibroin nanoparticles for dual anti-bacterial and anti-biofilm action.
- Author
-
Gopinath V, Mitra K, Chadha A, and Doble M
- Subjects
- 6-Phytase pharmacology, 6-Phytase metabolism, 6-Phytase chemistry, beta-Glucosidase metabolism, beta-Glucosidase chemistry, Microbial Sensitivity Tests, Glucose Oxidase pharmacology, Glucose Oxidase metabolism, Glucose Oxidase chemistry, Extracellular Polymeric Substance Matrix chemistry, Extracellular Polymeric Substance Matrix drug effects, Extracellular Polymeric Substance Matrix metabolism, alpha-Amylases metabolism, alpha-Amylases pharmacology, alpha-Amylases antagonists & inhibitors, Hydrophobic and Hydrophilic Interactions, Biofilms drug effects, Nanoparticles chemistry, Rifampin pharmacology, Fibroins chemistry, Fibroins pharmacology, Mycobacterium smegmatis drug effects, Enzymes, Immobilized chemistry, Enzymes, Immobilized pharmacology, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry
- Abstract
Biofilm formation is a major challenge in the treatment of tuberculosis, leading to poor treatment outcomes and latent infections. The complex and dense extracellular polymeric substances (EPS) of the biofilm provides safe harbour for bacterium enabling persistence against anti-TB antibiotics. In this study, we demonstrated that rifampicin-encapsulated silk fibroin nanoparticles immobilized with antibiofilm enzymes can disrupt the Mycobacterium smegmatis biofilm and facilitate the anti-bacterial action of Rifampicin (RIF). The EPS of M.smegmatis biofilm predominantly comprised of lipids (48.8 ± 1.32 %) and carbohydrates (34.8 ± 4.70 %), similar to tuberculosis biofilms. Pre-formed biofilm eradication screening revealed that hydrolytic enzymes such as β-Glucosidase, Glucose oxidase, ɑ-Amylase, Acylase, and Phytase can exhibit biofilm eradication of M.smegmatis biofilms. The enzyme-mediated biofilm disruption was associated with a decrease in hydrophobicity of biofilm surfaces. Treatment with β-glucosidase and Phytase demonstrated a putative biofilm eradication by reducing the total carbohydrates and lipid composition without causing any significant bactericidal activity. Further, Phytase (250 μg/ml) and β-Glucosidase (112.5 ± 17.6 μg/ml) conjugated rifampicin-loaded silk fibroin nanoparticles (R-SFNs) exhibited an enhanced anti-bacterial activity against pre-formed M.smegmatis biofilms, compared to free rifampicin (32.5±7 μg/ml). Notably, treatment with β-glucosidase, Phytase and ɑ-amylase immobilized SFNs decreased the biofilm thickness by ∼98.84 % at 6h, compared to control. Thus, the study highlights that coupling anti-mycobacterial drugs with biofilm-eradicating enzymes such as amylase, phytase or β-glucosidase can be a potential strategy to improve the TB therapeutic outcomes., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships with individual or other organization that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF